Golotimod is an orally bioavailable synthetic peptide containing the amino acids D-glutamine and L-tryptophan connected by a gamma-glutamyl linkage with potential immunostimulating, antimicrobial and antineoplastic activities.
More Information Supplier PageAplaviroc is a CCR5 entry inhibitor developed for the treatment of HIV infection.
More Information Supplier PageAplaviroc is a CCR5 entry inhibitor developed for the treatment of HIV infection.
More Information Supplier PageAplaviroc is a CCR5 entry inhibitor developed for the treatment of HIV infection.
More Information Supplier PageUramustine is a chemotherapy drug which belongs to the class of alkylating agents.
More Information Supplier PageUramustine is a chemotherapy drug which belongs to the class of alkylating agents.
More Information Supplier PageLuseogliflozin is an orally active second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor developed by Taisho Pharmaceutical for the treatment of patients with type 2 diabetes mellitus (T2DM).
More Information Supplier Page
